Ewelina Mazur

970 total citations · 1 hit paper
27 papers, 638 citations indexed

About

Ewelina Mazur is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Ewelina Mazur has authored 27 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Ewelina Mazur's work include Nonmelanoma Skin Cancer Studies (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Ewelina Mazur is often cited by papers focused on Nonmelanoma Skin Cancer Studies (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Ewelina Mazur collaborates with scholars based in Poland, Italy and Australia. Ewelina Mazur's co-authors include Kornelia Kędziora–Kornatowska, Remigiusz Sokołowski, Anna Polak-Szabela, Marta Podhorecka, Natalia Ciesielska, Adam Reich, Przemysław Gałązka, Alvisa Palese, Henryk Witmanowski and Anna Pilewska‐Kozak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancers and Frontiers in Oncology.

In The Last Decade

Ewelina Mazur

25 papers receiving 628 citations

Hit Papers

Is the Montreal Cognitive... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis
    2016 472 citations Natalia Ciesielska, Remigiusz Sokołowski et al. Psychiatria Polska profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewelina Mazur Poland 9 234 95 90 82 82 27 638
Marta Podhorecka Poland 10 258 1.1× 107 1.1× 107 1.2× 86 1.0× 77 0.9× 27 743
Anna Polak-Szabela Poland 5 256 1.1× 104 1.1× 76 0.8× 84 1.0× 75 0.9× 7 551
Remigiusz Sokołowski Poland 4 231 1.0× 95 1.0× 82 0.9× 83 1.0× 76 0.9× 14 506
Natalia Ciesielska Poland 3 222 0.9× 95 1.0× 75 0.8× 77 0.9× 74 0.9× 14 489
Olivier Beauchet France 13 331 1.4× 91 1.0× 175 1.9× 83 1.0× 111 1.4× 26 796
Anna M. Oleksik Netherlands 9 154 0.7× 107 1.1× 91 1.0× 157 1.9× 72 0.9× 9 654
María Lúcia Gurgel da Costa Brazil 5 211 0.9× 78 0.8× 76 0.8× 54 0.7× 54 0.7× 19 441
C. Elizabeth Shaaban United States 13 147 0.6× 56 0.6× 141 1.6× 50 0.6× 34 0.4× 46 510
Nadia Gildeh United Kingdom 7 274 1.2× 198 2.1× 178 2.0× 58 0.7× 70 0.9× 10 673

Countries citing papers authored by Ewelina Mazur

Since Specialization
Citations

This map shows the geographic impact of Ewelina Mazur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewelina Mazur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewelina Mazur more than expected).

Fields of papers citing papers by Ewelina Mazur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewelina Mazur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewelina Mazur. The network helps show where Ewelina Mazur may publish in the future.

Co-authorship network of co-authors of Ewelina Mazur

This figure shows the co-authorship network connecting the top 25 collaborators of Ewelina Mazur. A scholar is included among the top collaborators of Ewelina Mazur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewelina Mazur. Ewelina Mazur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazur, Ewelina, et al.. (2024). An Update on Non-Invasive Skin Imaging Techniques in Actinic Keratosis—A Narrative Review. Medicina. 60(7). 1043–1043. 4 indexed citations
2.
Mazur, Ewelina, et al.. (2024). Porokeratoses—A Rare Group of Dermatoses. Medicina. 60(11). 1876–1876.
3.
Mazur, Ewelina, et al.. (2023). Photodynamic Therapy in Pigmented Basal Cell Carcinoma—A Review. Biomedicines. 11(11). 3099–3099. 3 indexed citations
4.
5.
Mazur, Ewelina & Adam Reich. (2023). Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis. Dermatology and Therapy. 13(6). 1265–1276. 6 indexed citations
6.
Mazur, Ewelina, et al.. (2022). YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance. Frontiers in Oncology. 12. 856963–856963. 17 indexed citations
7.
Jundziłł, Arkadiusz, et al.. (2022). Resveratrol as a factor preventing skin agingand affecting its regeneration. Advances in Dermatology and Allergology. 39(3). 439–445. 23 indexed citations
8.
Żychowska, Magdalena, et al.. (2022). COVID-19 and Postural Control—A Stabilographic Study Using Rambling-Trembling Decomposition Method. Medicina. 58(2). 305–305. 8 indexed citations
9.
Gałązka, Przemysław, et al.. (2021). Itraconazole as a new pharmacotherapy methodin haemangiomas. Advances in Dermatology and Allergology. 38(6). 1122–1123. 3 indexed citations
10.
Mazur, Ewelina, et al.. (2020). Schisandrins impact on the efficiency of human body: A review. Science & Sports. 35(5). 271–278. 7 indexed citations
11.
Mazur, Ewelina, et al.. (2020). Pridopidine in the treatment of Huntington’s disease. Reviews in the Neurosciences. 31(4). 441–451. 11 indexed citations
12.
Mazur, Ewelina, et al.. (2020). Resveratrol in the treatment of neuroblastoma: a review. Reviews in the Neurosciences. 31(8). 873–881. 6 indexed citations
13.
Mazur, Ewelina, et al.. (2019). DELUSIONAL MISIDENTIFICATION SYNDROME: DISSOCIATION BETWEEN RECOGNITION AND IDENTIFICATION PROCESSES. Acta Neuropsychologica. 17(4). 456–467. 1 indexed citations
14.
Mazur, Ewelina, et al.. (2019). Endocrine systems of the skin. Advances in Dermatology and Allergology. 36(5). 519–523. 10 indexed citations
15.
Dobrowolska, Beata, et al.. (2019). Predicted difficulties, educational needs, and interest in working in end of life care among nursing and medical students. Nurse Education Today. 83. 104194–104194. 25 indexed citations
16.
Mazur, Ewelina, et al.. (2019). Metallo-Beta-Lactamases: NDM. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations
17.
18.
Mazur, Ewelina, et al.. (2018). Systemic lupus erythematosus of the urinary tract: focus on lupus cystitis. Reumatologia/Rheumatology. 56(4). 255–258. 6 indexed citations
19.
Mazur, Ewelina, et al.. (2018). Carbamazepine - Hematologic Effects Of The Use. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Ciesielska, Natalia, Remigiusz Sokołowski, Ewelina Mazur, et al.. (2016). Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatria Polska. 50(5). 1039–1052. 472 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Podhorecka Breakdown of academic impact, for papers by Anna Polak-Szabela Breakdown of academic impact, for papers by Remigiusz Sokołowski Breakdown of academic impact, for papers by Natalia Ciesielska Breakdown of academic impact, for papers by Olivier Beauchet Breakdown of academic impact, for papers by Anna M. Oleksik Breakdown of academic impact, for papers by María Lúcia Gurgel da Costa Breakdown of academic impact, for papers by C. Elizabeth Shaaban Breakdown of academic impact, for papers by Nadia Gildeh
Rankless by CCL
2026